437 related articles for article (PubMed ID: 19487259)
1. Facilitating the use of COBRA combination therapy in early rheumatoid arthritis: a pilot implementation study.
van Tuyl LH; Plass AM; Lems WF; Voskuyl AE; Kerstens PJ; Dijkmans BA; Boers M
J Rheumatol; 2009 Jul; 36(7):1380-6. PubMed ID: 19487259
[TBL] [Abstract][Full Text] [Related]
2. Discordant perspectives of rheumatologists and patients on COBRA combination therapy in rheumatoid arthritis.
van Tuyl LH; Plass AM; Lems WF; Voskuyl AE; Kerstens PJ; Dijkmans BA; Boers M
Rheumatology (Oxford); 2008 Oct; 47(10):1571-6. PubMed ID: 18710900
[TBL] [Abstract][Full Text] [Related]
3. Why are Dutch rheumatologists reluctant to use the COBRA treatment strategy in early rheumatoid arthritis?
van Tuyl LH; Plass AM; Lems WF; Voskuyl AE; Dijkmans BA; Boers M
Ann Rheum Dis; 2007 Jul; 66(7):974-6. PubMed ID: 17392349
[TBL] [Abstract][Full Text] [Related]
4. Tight control and intensified COBRA combination treatment in early rheumatoid arthritis: 90% remission in a pilot trial.
van Tuyl LH; Lems WF; Voskuyl AE; Kerstens PJ; Garnero P; Dijkmans BA; Boers M
Ann Rheum Dis; 2008 Nov; 67(11):1574-7. PubMed ID: 18625629
[TBL] [Abstract][Full Text] [Related]
5. Intensive combination treatment regimens, including prednisolone, are effective in treating patients with early rheumatoid arthritis regardless of additional etanercept: 1-year results of the COBRA-light open-label, randomised, non-inferiority trial.
ter Wee MM; den Uyl D; Boers M; Kerstens P; Nurmohamed M; van Schaardenburg D; Voskuyl AE; Lems WF
Ann Rheum Dis; 2015 Jun; 74(6):1233-40. PubMed ID: 24818633
[TBL] [Abstract][Full Text] [Related]
6. Indirect and total costs of early rheumatoid arthritis: a randomized comparison of combined step-down prednisolone, methotrexate, and sulfasalazine with sulfasalazine alone.
Korthals-de Bos I; Van Tulder M; Boers M; Verhoeven AC; Adèr HJ; Bibo J; Boonen A; Van Der Linden S
J Rheumatol; 2004 Sep; 31(9):1709-16. PubMed ID: 15338488
[TBL] [Abstract][Full Text] [Related]
7. Initial high-dose prednisolone combination therapy using COBRA and COBRA-light in early rheumatoid arthritis.
Rasch LA; van Tuyl LH; Lems WF; Boers M
Neuroimmunomodulation; 2015; 22(1-2):51-6. PubMed ID: 25227967
[TBL] [Abstract][Full Text] [Related]
8. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG
Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739
[TBL] [Abstract][Full Text] [Related]
9. Treatment of pregnant and non-pregnant rheumatic patients: a survey among Dutch rheumatologists.
Vroom F; van de Laar MA; van Roon EN; Brouwers JR; de Jong-van den Berg LT
J Clin Pharm Ther; 2008 Feb; 33(1):39-44. PubMed ID: 18211615
[TBL] [Abstract][Full Text] [Related]
10. Most rheumatologists are conservative in active rheumatoid arthritis despite methotrexate therapy: results of the PRISME survey.
Saraux A; Devauchelle-Pensec V; Engerran L; Flipo RM
J Rheumatol; 2006 Jul; 33(7):1258-65. PubMed ID: 16783865
[TBL] [Abstract][Full Text] [Related]
11. Providing patients with information about disease-modifying anti-rheumatic drugs: Individually or in groups? A pilot randomized controlled trial comparing adherence and satisfaction.
Homer D; Nightingale P; Jobanputra P
Musculoskeletal Care; 2009 Jun; 7(2):78-92. PubMed ID: 18792423
[TBL] [Abstract][Full Text] [Related]
12. Practice variation in the treatment of rheumatoid arthritis among German rheumatologists.
Zink A; Listing J; Ziemer S; Zeidler H;
J Rheumatol; 2001 Oct; 28(10):2201-8. PubMed ID: 11669156
[TBL] [Abstract][Full Text] [Related]
13. Prescribing trends in disease modifying antirheumatic drugs for rheumatoid arthritis: a survey of practicing Canadian rheumatologists.
Pope JE; Hong P; Koehler BE
J Rheumatol; 2002 Feb; 29(2):255-60. PubMed ID: 11838842
[TBL] [Abstract][Full Text] [Related]
14. Longterm observational study of methotrexate use in a Dutch cohort of 1022 patients with rheumatoid arthritis.
Hoekstra M; van de Laar MA; Bernelot Moens HJ; Kruijsen MW; Haagsma CJ
J Rheumatol; 2003 Nov; 30(11):2325-9. PubMed ID: 14677172
[TBL] [Abstract][Full Text] [Related]
15. An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists.
van Roon EN; van den Bemt PM; Jansen TL; Houtman NM; van de Laar MA; Brouwers JR
Clin Ther; 2009 Aug; 31(8):1737-46. PubMed ID: 19808132
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of efficacy and tolerability of triple combination therapy (methotrexate + sulfasalazine + hydroxychloroquine) with methotrexate monotherapy in patients with rheumatoid arthritis].
Gubar' EE; Bochkova AG; Bunchuk NV
Ter Arkh; 2008; 80(5):25-30. PubMed ID: 18590110
[TBL] [Abstract][Full Text] [Related]
17. How Canadian and US rheumatologists treat moderate or aggressive rheumatoid arthritis: a survey.
Maetzel A; Bombardier C; Strand V; Tugwell P; Wells G
J Rheumatol; 1998 Dec; 25(12):2331-8. PubMed ID: 9858426
[TBL] [Abstract][Full Text] [Related]
18. [Combination therapy in early rheumatoid arthritis: the COBRA study].
Boers M; Verhoeven AC; van der Linden S
Ned Tijdschr Geneeskd; 1997 Dec; 141(50):2428-32. PubMed ID: 9555126
[TBL] [Abstract][Full Text] [Related]
19. Common polymorphisms in the folate pathway predict efficacy of combination regimens containing methotrexate and sulfasalazine in early rheumatoid arthritis.
James HM; Gillis D; Hissaria P; Lester S; Somogyi AA; Cleland LG; Proudman SM
J Rheumatol; 2008 Apr; 35(4):562-71. PubMed ID: 18322994
[TBL] [Abstract][Full Text] [Related]
20. Variations and trends in the prescription of initial second line therapy for patients with rheumatoid arthritis.
Galindo-Rodriguez G; Avina-Zubieta JA; Fitzgerald A; LeClerq SA; Russell AS; Suarez-Almazor ME
J Rheumatol; 1997 Apr; 24(4):633-8. PubMed ID: 9101493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]